Figure 5.
Median PSA at baseline and after SBRT for both dose groups and for patients treated with or without hormones (=/- standard deviation). Dose did not significantly alter PSA levels over time.
Median PSA at baseline and after SBRT for both dose groups and for patients treated with or without hormones (=/- standard deviation). Dose did not significantly alter PSA levels over time.